Lysophosphatidic acid receptor-2 (LPA2) and LPA5 regulate cellular functions during tumor progression in fibrosarcoma HT1080 cells-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Lysophosphatidic acid receptor-2 (LPA2) and LPA5 regulate cellular functions during tumor progression in fibrosarcoma HT1080 cells

Published:2018-09 Issue:4 Volume:503 Page:2698-2703
ISSN:0006-291X
Container-title:Biochemical and Biophysical Research Communications
language:en
Short-container-title:Biochemical and Biophysical Research Communications

Author:

Takahashi Kaede,Minami Kanako,Otagaki Shiho,Ishimoto Kaichi,Fukushima Kaori,Fukushima Nobuyuki,Honoki Kanya,Tsujiuchi Toshifumi

Funder

JSPS KAKENHI

Faculty of Science and Engineering, Kindai University

Publisher

Elsevier BV

Subject

Cell Biology,Molecular Biology,Biochemistry,Biophysics

Reference20 articles.

1. Two pathway for lysophosphatidic acid production;Aoki;Biochim. Biophys. Acta,2008

2. LPA receptors: subtypes and biological actions;Choi;Annu. Rev. Pharmacol. Toxicol.,2010

3. Lysophosphatidic acid as a lipid mediator with multiple biological actions;Aikawa;J. Biochem.,2015

4. Promising pharmacological directions in the world of lysophosphatidic acid signaling;Stoddard;Biomol. Ther.,2015

5. LPA receptor signaling: pharmacology, physiology, and pathophysiology;Yung;J. Lipid Res.,2014

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Lysophosphatidic acid (LPA) receptor modulators: Structural features and recent development;European Journal of Medicinal Chemistry;2021-10

2. Lysophosphatidic Acid Receptor Antagonists and Cancer: The Current Trends, Clinical Implications, and Trials;Cells;2021-06-29

3. Six Immune Associated Genes Construct Prognostic Model Evaluate Low-Grade Glioma;Frontiers in Immunology;2020-12-21

4. Cooperation of G12/13 and Gi proteins via lysophosphatidic acid receptor-2 (LPA2) signaling enhances cancer cell survival to cisplatin;Biochemical and Biophysical Research Communications;2020-11

5. Establishment of a Jaw Fibrosarcoma Patient-Derived Xenograft and Evaluation of the Tumor Suppression Efficacy of Plumbagin Against Jaw Fibrosarcoma;Frontiers in Oncology;2020-08-27

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3